Matinas BioPharma Investor Relations Material

Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of various product candidates for the treatment of cancer and other orphan diseases. The company explores next-generation chemotherapeutic drugs that bring an optimal therapeutic benefit to patients with high unmet medical needs. One of the company's lead drug candidates is for the treatment of tumors resistant to conventional therapies such as chemotherapy or radiation therapy.